What drove the SKIN.SW stock rise on 13 Jan 2026?

The SKIN.SW stock jump of **9.85%** was on above-average volume (2,756) and likely tied to clinical or corporate news and thin liquidity that magnifies moves. No formal earnings release was scheduled for the day.

What valuation metrics matter for SKIN.SW stock?

Key metrics: **EPS -1.27**, **PE -28.13**, **PB 25.56**, cash per share **CHF 0.25**, current ratio **1.98**. These show negative earnings and valuation skew due to small float.

What price target does Meyka AI have for SKIN.SW stock?

Meyka AI's forecast model projects a base-case **CHF 42.50**, which implies **19.05%** upside from the current **CHF 35.70**. Forecasts are model projections and not guarantees.

How liquid is SKIN.SW stock for traders?

Liquidity is limited: average volume **1,818** and today’s volume **2,756** indicate thin trading. That raises volatility and execution risk for large orders.

CH Stocks

SKIN.SW (Cassiopea S.p.A., SIX) up 9.85% on high volume 13 Jan 2026: Monitor catalyst

ByDanny Kontos January 14, 2026January 14, 2026

The SKIN.SW stock surged 9.85% to CHF 35.70 on 13 Jan 2026 on volume above average, signaling a high-volume mover on the SIX Swiss Exchange. Trading opened at CHF 32.00 and hit a session high of CHF 36.00 before close. Volume reached 2,756 shares versus an average of 1,818, a relative volume of 1.52. This move follows ongoing clinical development updates and thin liquidity that can amplify price swings in biotechnology names.